Abstract: A biomaterial includes keratin proteins crosslinked with linking groups chosen from thiosuccinimide, thioether sulfone, and mixtures and combinations thereof.

Abstract: The present document discloses a method for measuring the carrier-envelope phase, CEP, offset of ultrashort light pulses, the method comprising: generating an optical interference signal encoding the CEP offset of a light pulse to be measured; applying at least two spectral filters in parallel to the generated interference signal, wherein the transmission functions of the spectral filters are periodic and the at least two spectral filters have partial or fully orthogonal components among themselves; detecting each signal filtered by each of the at least two spectral filters to obtain a magnitude for each of the filtered signals; converting the two obtained magnitudes to a polar representation having a radius and an angle; outputting the CEP offset from the angle of the converted polar representation. It is also disclosed a corresponding system, a field-resolved spectrometer including the system and the use of the system in spectroscopy or in field-resolved spectroscopy.

Abstract: The present disclosure relates to compounds for RNA capping and uses thereof, which belong to the technical field of genetic engineering. Compounds of formula I can result in high levels of capping efficiency, and the capped mRNA exhibits a high transcription level and increased expression.

Abstract: The present disclosure relates to laser systems and laser pulse measurement methods.

Abstract: Provided are a HEK293T cell strain having high dispersibility and a screening method therefor. Specifically, the present application relates to a method for screening a HEK293T cell strain suitable for serum-free suspension culture, a cell strain screened by using the method, and a method for producing a viral vector by using the cell strain.

Abstract: A novel imidazothiazole compound as an Autotaxin inhibitor, a pharmaceutical composition including the compound, and a use thereof in a treatment of a disease with a pathological feature of Autotaxin overexpression in a mammal is provided, wherein the compound has a structure of formula (I), or a pharmaceutically acceptable salt, hydrate, solvate, stereoisomer, tautomer, nitrogen oxide, metabolite, prodrug, or mixture thereof; wherein each of R1a, R1c, R2, R3, R6, Cy, Y, Z, and t is defined as described in the present disclosure.

Abstract: The present disclosure provides a method for continuously and efficiently preparing taurine, including:(a) bringing an ethylene oxide with an alkali metal bisulfite into an addition reaction to obtain an alkali metal isethionate; (b) bringing the alkali metal isethionate with an ammonia into an ammonolysis reaction to obtain a solution containing alkali metal taurinate; and (c) inputting the solution containing alkali metal taurinate into at least one acid cation exchange resin column in activated state to obtain the taurine through an acidification treatment, followed by activating a portion of the at least one acid cation exchange resin column by a first activation manner using sulfurous acid and obtaining a solution containing alkali metal bisulfite, and activating another portion of the at least one acid cation exchange resin column by a second activation manner using sulfuric acid, wherein the first and second activation manner may be performed on a same acid cation exchange resin column alternatingly or

Abstract: The present disclosure provides a system for efficiently preparing taurine, including: a solution storage unit configured to store a solution containing alkali metal taurinate, the solution being prepared by an ethylene oxide process; an ion exchange unit including at least one ion exchange resin column each configured to be activated by a first activation manner or a second activation manner independently, the first activation manner using sulfurous acid for activation to obtain alkali metal bisulfate and taurine, and the second activation manner using sulfuric acid for activation to obtain alkali metal sulfate and taurine; and a dispensing unit connected to the solution storage unit and the ion exchange unit respectively, and configured to adjust an amount of a solution conveyed from the solution storage unit to each of the at least one ion exchange resin column in the ion exchange unit.

Abstract: The present disclosure is generally directed to an embolic material in the form of a microparticle. The embolic material generally includes an alkene functionalized biopolymer. For instance, the embolic material may include a methacrylamide functionalized biopolymer. In some examples, the embolic material may further comprise a therapeutic agent, such as doxorubicin.

Abstract: The present disclosure relates to compounds for RNA capping and uses thereof, which belong to the technical field of genetic engineering. Compounds of formula I can result in high levels of capping efficiency, and the capped mRNA exhibits a high transcription level and increased expression.

Abstract: The present disclosure provides a method (400) for facilitating Antenna Calibration, AC. The method (400) includes: identifying (410) a leakage signal from a signal received at an AC signal receiver and resulted from a reference signal originated from an AC signal transmitter passing through an AC signal path from the AC signal transmitter to the AC signal receiver; and cancelling (420) an influence of the leakage signal on an AC process.

Abstract: A Dual-Purpose Desktop Charger for compensating for the various sizes of personal electronic devices. A dual-purpose charger that includes a multi-port wired charging panel with the integration of an axel mechanism that allows for a multi-positional wireless charging pad.

Abstract: The present disclosure provides a system for efficiently preparing taurine, including: a solution storage unit configured to store a solution containing alkali metal taurinate, the solution being prepared by an ethylene oxide process; an ion exchange unit including at least one ion exchange resin column each configured to be activated by a first activation manner or a second activation manner independently, the first activation manner using sulfurous acid for activation to obtain alkali metal bisulfate and taurine, and the second activation manner using sulfuric acid for activation to obtain alkali metal sulfate and taurine; and a dispensing unit connected to the solution storage unit and the ion exchange unit respectively, and configured to adjust an amount of a solution conveyed from the solution storage unit to each of the at least one ion exchange resin column in the ion exchange unit.

Abstract: Provided is a catalyst for preparing high-purity taurine, and the catalyst is N,N-disubstituted aminoethanesulfonic acid and has a structure represented by Formula I, in which R1 and R2 are each independently selected from alkyl, alkenyl, alkynyl, alkoxy, benzyl, sulfhydryl, thioether group, aryl, heteroaryl, amino, amide, imide, cyano, aldehyde group, carbonyl, carboxyl, sulfonic acid group, or ester group. Also provided is a method for preparing high-purity taurine, which adds the catalyst in an ammonolysis step for preparing taurine, thereby having effects of high yield, inhibition of impurity production and a reduced amount of ammonia used, etc. The catalyst has advantages of low cost, stable physical properties, and easy separation from the product. The preparation method is simple to operate with easily available raw materials and high yield, and can be employed for industrial production. Moreover, the purity of the prepared taurine can be up to 98% or higher.

Abstract: A stability measuring method for a synchronous generator includes: S11: collecting electrical quantities, and setting an alarm PQ curve of the synchronous generator; S12: calculating a dynamic reactive power reserve, an inductive dynamic reactive power reserve and a capacitive dynamic reactive power reserve of the synchronous generator; S13: calculating a dynamic reactive power reserve target value, an inductive dynamic reactive power reserve target value and a capacitive dynamic reactive power reserve target value of the synchronous generator; and S14: calculating a capacitive stability, an inductive stability and a stability of the synchronous generator.

Abstract: The present disclosure relates to laser systems and laser pulse measurement methods.

Abstract: Methods and systems are provided that may be utilized to detect occurrence of one or more specified circumstances. A determination may be made as to whether one or more specified circumstances are detected such as responsive to one or more user actions or an occurrence of an event unrelated to a user. One or more binary digital signals may be generated to store a detection of one or more specified user circumstances in a log or memory at least partially in response to detection of the one or more specified circumstances.